Opioid prescriptions in the emergency department (ED) were associated with small increases in later opioid prescriptions and hospital admissions, found new research published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.241542.
AstraZeneca joins Boehringer Ingelheim in capping out-of-pocket inhaler costs at $35
Just as insulin manufacturers were pressured into capping monthly out-of-pocket costs, inhaler manufacturers are feeling the same heat. AstraZeneca on Monday joined with Boehringer Ingelheim